The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-4-(2-(2-(3-cyanophenyl)-1-hydroxy-4-methyl-1H-imidazole-5-carboxamido)-3-phenylpropanamido)benzoic acid ID: ALA4860514
PubChem CID: 164616045
Max Phase: Preclinical
Molecular Formula: C28H23N5O5
Molecular Weight: 509.52
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(-c2cccc(C#N)c2)n(O)c1C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccc(C(=O)O)cc1
Standard InChI: InChI=1S/C28H23N5O5/c1-17-24(33(38)25(30-17)21-9-5-8-19(14-21)16-29)27(35)32-23(15-18-6-3-2-4-7-18)26(34)31-22-12-10-20(11-13-22)28(36)37/h2-14,23,38H,15H2,1H3,(H,31,34)(H,32,35)(H,36,37)/t23-/m0/s1
Standard InChI Key: LRNZBNKGAAZXIU-QHCPKHFHSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
40.0424 -3.2853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7501 -2.8767 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.4578 -3.2853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4553 -4.1035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1621 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8708 -4.1034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8682 -3.2820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1607 -2.8772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5791 -4.5111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5802 -5.3282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.2862 -4.1015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.3347 -2.8767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6270 -3.2853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.9192 -2.8767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0424 -4.1025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.3347 -2.0595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0424 -1.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7496 -2.0624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4569 -1.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4573 -0.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7446 -0.4280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0403 -0.8383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9192 -2.0595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2115 -3.2853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4636 -2.9573 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9168 -3.5646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3255 -4.2723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1247 -4.1023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7318 -4.6494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2915 -2.1584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.1089 -3.4814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7773 -2.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9654 -2.6476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4842 -3.3092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8207 -4.0585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6316 -4.1406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3481 -4.7213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8701 -5.3841 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
6 9 1 0
9 10 2 0
9 11 1 0
1 12 1 0
12 13 1 0
13 14 1 0
1 15 2 0
12 16 1 1
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
14 23 2 0
14 24 1 0
24 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 24 2 0
28 29 1 0
25 30 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
26 31 1 0
37 38 3 0
35 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 509.52Molecular Weight (Monoisotopic): 509.1699AlogP: 3.65#Rotatable Bonds: 8Polar Surface Area: 157.34Molecular Species: ACIDHBA: 7HBD: 4#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.18CX Basic pKa: 2.76CX LogP: 2.76CX LogD: -0.08Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -1.13
References 1. Lei Y, Zhang B, Zhang Y, Dai X, Duan Y, Mao Q, Gao J, Yang Y, Bao Z, Fu X, Ping K, Yan C, Mou Y, Wang S.. (2021) Design, synthesis and biological evaluation of novel FXIa inhibitors with 2-phenyl-1H-imidazole-5-carboxamide moiety as P1 fragment., 220 [PMID:33894565 ] [10.1016/j.ejmech.2021.113437 ]